On October 23, 2026, the Board of Directors of Faeth Therapeutics, Inc., also known as Sensei Biotherapeutics, Inc., increased the size of the Board from six to seven directors and appointed Adam Schayowitz to serve as a Class III director, effective immediately. Dr. Schayowitz w